IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.040
+0.030 (2.97%)
At close: May 26, 2026, 4:00 PM EDT
1.040
0.00 (-0.03%)
After-hours: May 26, 2026, 7:25 PM EDT
IRIDEX Revenue
IRIDEX had revenue of $11.80M in the quarter ending April 4, 2026, a decrease of -0.82%. This brings the company's revenue in the last twelve months to $52.58M, up 7.73% year-over-year. In the fiscal year ending January 3, 2026, IRIDEX had annual revenue of $52.68M with 8.23% growth.
Revenue (ttm)
$52.58M
Revenue Growth
+7.73%
P/S Ratio
0.34
Revenue / Employee
$565,355
Employees
93
Market Cap
18.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 3, 2026 | 52.68M | 4.01M | 8.23% |
| Dec 28, 2024 | 48.67M | -3.20M | -6.17% |
| Dec 30, 2023 | 51.87M | -5.10M | -8.96% |
| Dec 31, 2022 | 56.97M | 3.07M | 5.69% |
| Jan 1, 2022 | 53.90M | 17.56M | 48.30% |
| Jan 2, 2021 | 36.35M | -7.10M | -16.34% |
| Dec 28, 2019 | 43.45M | 847.00K | 1.99% |
| Dec 29, 2018 | 42.60M | 1.01M | 2.42% |
| Dec 30, 2017 | 41.59M | -4.57M | -9.89% |
| Dec 31, 2016 | 46.16M | 4.40M | 10.54% |
| Jan 2, 2016 | 41.76M | -1.06M | -2.47% |
| Jan 3, 2015 | 42.81M | 4.54M | 11.86% |
| Dec 28, 2013 | 38.27M | 4.41M | 13.04% |
| Dec 29, 2012 | 33.86M | 700.00K | 2.11% |
| Dec 31, 2011 | 33.16M | 851.00K | 2.63% |
| Jan 1, 2011 | 32.31M | 1.28M | 4.11% |
| Jan 2, 2010 | 31.03M | - | - |
| Jan 3, 2009 | - | - | - |
| Dec 29, 2007 | - | - | - |
| Dec 30, 2006 | 35.90M | -1.13M | -3.04% |
| Dec 31, 2005 | 37.03M | 4.22M | 12.86% |
| Jan 1, 2005 | 32.81M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| Cytosorbents | 37.20M |
| Lifeward | 20.92M |
| Pulsenmore | 12.55M |
| Picard Medical | 5.47M |
| IceCure Medical | 3.57M |
| VolitionRx | 2.47M |
| Sintx Technologies | 1.03M |
IRIX News
- 7 days ago - IRIDEX Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - IRIDEX Earnings release: Q1 2026 - Filings
- 7 days ago - IRIDEX Quarterly report: Q1 2026 - Filings
- 7 days ago - Iridex Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 21 days ago - Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 - GlobeNewsWire
- 4 weeks ago - IRIDEX Proxy statement: Proxy filing - Filings
- 4 weeks ago - IRIDEX Proxy statement: Proxy filing - Filings
- 7 weeks ago - Iridex announces new partnership with EyeProGPO - TheFly